| Autor: |
ayón-Pérez, Miriam F., Pimentel-Gutiérrez, Helia J., Durán-avelar, Ma. de Jesús, Vibanco-Pérez, Norberto, Pérez-Peraza, Víctor M., Pérez-González, Óscar a., Barrientos-Ríos, Rehotbevely, Santillán-Ávila, Christian F., Zambrano-Zaragoza, José F., agraz-Cibrián, Juan M., Gutiérrez-Franco, Jorge, Vázquez-Reyes, alejandro |
| Předmět: |
|
| Zdroj: |
Cytogenetic & Genome Research; Jun2019, Vol. 157 Issue 4, p10-16, 7p, 3 Charts |
| Abstrakt: |
The IKZF1 gene is formed by 8 exons and encodes IKAROS, a transcription factor that regulates the expression of genes that control cell cycle progression and cell survival. In general, 15-20% of the patients with preB acute lymphoblastic leukemia (preB ALL) harbor IKZF1 deletions, and the frequency of these deletions increases in BCR-ABL1 or Ph-like subgroups. These deletions have been associated with poor treatment response and the risk of relapse. The aim of this descriptive study was to determine the frequency of IKZF1 deletions and the success of an induction therapy response in Mexican pediatric patients diagnosed with preB ALL in 2 hospitals from 2017 to August 2018. Thirty-six bone marrow samples from patients at the Instituto Nacional de Pediatría in Mexico City and the Centro Estatal de Cancerología in Tepic were analyzed. The IKZF1 deletion was identified by MLPA using the SALSA MLPA P335 ALL-IKZF1 probemix. Deletions of at least 1 IKZF1 exon were observed in 7/34 samples (20.6%): 3 with 1 exon deleted; 1 with 2 exons, 1 with 5 exons, 1 with 6 exons, and 1 patient with a complete IKZF1 deletion. This study was descriptive in nature; we calculated the frequency of the IKZF1 gene deletion in a Mexican pediatric population with preB ALL as 20.6%. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
